Summary. The (Na+-K+)ATPase and (Mg2+)ATPase activities of erythrocyte membranes of Type 1 (insulin-dependent) diabetic patients were found to be significantly reduced compared to matched controls (p < 0.005). On the contrary, erythrocyte Na + and K + contents were similar in diabetic patients and in normal subjects. When erythrocyte membranes from diabetic patients were incubated with their own plasma, a significant increase was observed in sodium-potassium ATPase activity (p <0.005), whereas (Mg2+)ATPase activity was not affected. The plasma stimulatory effect showed saturation kinetics. Maximum average stimulation was 96% (+21.3). A similar stimulation pattern, although more limited in extent (maximum 48.3% + 12.2), was found when erythrocyte membranes from normal subjects were incubated with diabetic plasma. Normal plasma exhibited a modest stimulatory effect on erythrocyte (Na+-K+)ATPase activity. Similar stimulatory effects by diabetic plasma were observed on a (Na+-K +) ATPase preparation from beef heart. It is proposed that diabetic plasma contains a specific (Na+-K+)ATPase activator in a higher concentration than normal plasma. This may explain why a normal cellular electrolyte content was found in diabetic erythrocytes in spite of a reduced Na +-K + pump activity. Purification experiments indicate that the plasma activator is a protein with a molecular weight greater than 50,000. Both the (Na+-K+)ATPase activity and the stimulatory effect of diabetic plasma were not influenced by the metabolic control, since they did not correlate significantly with fasting blood glucose and daily insulin dosage. Moreover, no correlation was found with duration of diabetes or age at diagnosis of diabetes. It is suggested that the enzyme defect of erythrocyte membrane and the stimulation of (Na+-K+)ATPase activity by homologous plasma are early biochemical alterations in the course of diabetes mellitus.
It is well known that hypertension, along with other vascular complications, occurs more frequently in diabetic patients than in the normal population [1] . The relationship between diabetes and this form of vascular disease has not been clearly defined. Duration of diabetes and hyperglycaemia have been reported as vascular risk factors [2, 3] , although some Type I diabetic patients have been shown to be lesion free despite long duration of the disease [4] or poor metabolic control [5] . It has been recently found that a strict metablic control does not slow, but rather worsens the progression of microangiopathies in diabetes [6, 7] . Hypertension has also been observed to be more common in diabetic patients before the onset of clinical disease. Therefore, it has been taken as an indicator of increased risk of diabetes [1] . Moreover, hypertensive, apparently non-diabetic subjects frequently show an impaired glucose tolerance [8] . Thus, it has been suggested that vascular diseases associated with diabetes are not the consequence of metabolic derangement, but rather of a primary biochemical lesion which precedes the clinically overt disease [5, 9, 10] . An impairment of cation transport systems, including (Na+-K+)ATPase, has been reported in blood cell membranes of essential hypertensive subjects before the onset of the rise in blood pressure; this damage has been considered as a genetic marker of susceptibility to the disease [11, 12] . Given the higher incidence of vascular pathology in diabetic patients compared to control subjects, it is conceivable that similar biochemical lesions occur also in diabetic cellular membranes when no vascular complications are yet clinically detectable. To test this possibility, a selected group of Type 1 (insulin-dependent) normotensive diabetic patients was tested for erythrocyte Na + and K + contents and for (Na+-K+)ATPase and (MgZ+)ATPase activities of the erythrocyte membrane. Fasting blood glucose and glycosylated haemoglobin (HbA0 were also analyzed in order to detect their relation, if any, with erythrocyte cation content and enzymatic activies.
Subjects and methods

Subjects
The subjects selected for this study were 62 Type 1 diabetic patients attending the Diabetes Centre (32males and 30females, mean age 32+1.45 years, range 16-52) and 49 control subjects (25 males and 24 females, mean age 25 ___ 1.17 years, range . Patients were in a good state of health (documented by normal values of biochemical and clinical indices) and free of clinically apparent complications (retinopathy, neuropathy, hypertension) assessed by laboratory and clini- Values are expressed as mean+ SEM. ~ Mean (_+ SEM) of eleven subjects cal measurements. Diabetic patients were of normal weight and in acceptable metabolic control (no severe hypo-hyperglycaemic episodes in the last three months). Duration of diabetes, age at diagnosis of diabetes and other clinical findings of the diabetic and control groups are summarized in Table 1 . Factors such as hypertension history in the family and drug consumption, which are known to alter the intracellular cation content [13] [14] [15] or ATPase activity [16] , were accurately avoided in selecting patients. Control subjects were normotensive, drug-free, non-diabetic subjects with a negative family history of diabetes and essential hypertension. Diabetic patients and control subjects were analyzed randomly for erythrocyte Na + and K + contents and for (Na+-K+)ATPase and (Mg~+)ATPase activities, under identical fasting and resting conditions, and by the same investigator.
Cation determination
Freshly heparinized blood was centrifuged for 15 min at 1800 g. Plasma and buffy coat were carefully removed by aspiration. The packed erythrocytes were transferred into polyethylene tubes (1.5 ml) and centrifuged twice at 8470xg for 15min to remove the residual amount of plasma. Each tube was weighed before being filled and after the last centrifugation. The difference between the two weights was considered as the net weight of erythrocytes [14] . The packed cells were then lysed in 30 ml of ice-cold deionized water by vigorous shaking. Na + and K + contents in the haemolysate were measured by a flame emission spectrophotometer and expressed as mmol/kg of erythrocytes. The volume of the trapped plasma was constant and of the same value in both diabetic patients and control subjects (3% of the weighed cells). Each sample was analyzed in triplicate so that the values reported are the mean of three separate haemolysates obtained from the same sample with a within determination error less than 3% coefficient of variation (C. V.). Interassay variability (calculated from measurements made on different days on the same subjects) ranged from 3.8% to 4.6% C.V. in fifteen different subjects.
Membrane preparation and A TPase assay
The erythrocyte membranes from freshly heparinized blood were prepared according to Raess and Vincenzi [17] . Briefly, the heparinized blood samples were washed three times with 4 volumes of 0.9% NaC1 and centrifuged for 5 min at 3000 x g. Erythrocytes were haemolyzed in 20 mmol/1 imidazole pH 7.4 with a 1:14 cell to buffer ratio. After vigorous shaking the suspension was centrifuged for 15min at 35,000 x g. The membrane pellet was washed twice with 35 ml and, subsequently, twice with 20ml of 20mmol/1 imidazole buffer (pH 7.4). After each centrifugation (25.000 x g for 15 min), the supernatant was removed. For the last wash, 20 ml of histidine-imidazole buffer (40 mmol/1 each, pH 7.4) was used. The white membranes from both normal and diabetic erythrocytes were rapidly frozen in liquid N2 and stored at -40°C. Each sample was used immediately after thawing. Proteins were measured by the method of Lowry et al. [18] . The mean protein content of erythrocyte membrane suspension was 3.45 mg/ml (+ 0.14) for control subjects and 3.31 mg/ml (_+ 0.12) for diabetic patients. ATPase activity was determined by means of the Fiske and Subbarow [19] phosphate assay as previously described in detail [20] . The incubation medium contained, in a final volume of 1 ml: 100mmol NaC1, 20 mmol KC1, 3 mmol MgC12, 3 mmol ATP (pH 7.1), istidine-imidazole buffer (18 mmol each, pH 7.1), 0.1 mmol EGTA. The (Na+-K+)ATPase activity was calculated by subtracting the activity in the presence of 0.2 mmol ouabain (MgZ+ATPase) from that in the absence of ouabain (total activity) and correcting it for appropriate blank. The reaction was started by the addition of 100 ~tl of membrane suspension (containing 0.2-0.35 mg protein) and terminated after 60 min of incubation at 37 °C by the addition of 0.25 ml of 50% trichloroacetic acid. Product formation was linear with time throughout the incubation period. The reported ATPase activities represent the mean of duplicates with an intra-assay error of less than 2.5% C.V. The values obtained for control subjects were in accordance with those previously reported by others [21] .
Cross-incubation experiments
Fifteen healthy and fifteen diabetic subjects were studied for cross-incubation experiments. In these experiments plasma of each subject was obtained by blood centrifugation at 600 x g for 15 rain at room temperature, dialyzed for 24 h at 4 °C in Spectrapor membrane tubing (mol.wt cut-off 12.000; Arthur H. Thomas Co. Philadelphia, Pa, USA) against 50volumes of a buffer solution of imidazole-histidine (40 mmol/1 each; pH 7.1), frozen and utilized immediately after thawing at scalar dilutions. Dialysis was performed since at the higher concentrations used non-dialyzed plasma interfered with the method for determination of enzyme activity. Erythrocyte membranes of each diabetic patient were incubated with their own plasma and with plasma from a control subject by random sequence. The same procedure was used for erythrocyte membranes of normal subjects, Conditions of incubation were the same as described above. In different experiments plasma from diabetic patients and from control subjects was also tested in scalar concentrations on partially purified beef heart (Na+-K+)ATPase prepared according to Matsui and Schwartz [22] . The activity of this enzyme preparation was determined as specified above except that the amount of proteins added to the incubation medium was 20-30 Ixg.
Procedures for characterizing plasma activating factor
Plasma protein denaturation was performed at 0 °C. Plasma (0.5 ml) was added to 0.66 N perchloric acid (0.5 ml). The samples were centrifuged at 10,000 g for 10rain and the supernatants neutralized with 2 M KHCO3. The insoluble material was removed by centrifugation (10,000 × g for 10 min) and the clear supernatant tested at scalar dilutions on beef heart (Na+-K+)ATPase activity. The lipid extraction from plasma was performed by adding to the plasma sample 20 volumes of chloroform/methanol (2:1, v/v). The mixtures were stirred overnight at 4 °C and the extract evaporated under low pressure. The dry residue was taken up in imidazole-histidine buffer (180 mmol/1 each; pH 7A), sonicated for 1 min and added to the ATPase assay in scalar dilutions in order to test stimulation.
Ultrafiltration of plasma and serum samples was performed using Amicon CF50A membrane cones (95% retention for molecules above 50,000; Amicon Corp. Lexington, Mass, USA).
Table2. Mean (+_SEM) erythrocyte Na + and K + content (mmol/kg erythrocyte), total (Na+-K+-Mg2+)ATPase, ouabain-sensitive (Na +-K+)ATPase and ouabain-insensitive (MgZ+)ATPase activities 0xmol. mg -1. h-lxl02) in control subjects (n = 49) and in Type 1 diabetic patients (n = 62) 
Statistical analysis
The results are expressed as mean + SEM or mean + SD where indicated. Statistical analyses were made by two-tailed Student's t-test for unpaired data, or by two-tailed Wilcoxon's signed-rank test and Wilcoxon's rank sum test, when appropriate [23] . Linear correlation analysis was also used.
Results
The mean erythrocyte Na + and K + contents of diabetic patients and control subjects were very similar ( Table 2) . ATPase activities of erythrocyte membranes were, on the contrary, significantly reduced in diabetic patients with respect to control subjects (p < 0.005 for each comparison; Table 2 ). Since it was verified that the ATPase activity was constant with time throughout the incubation period, it can be excluded that the decrease in enzyme activity found in the diabetic group was due to an increased rate of enzyme decay during the assay. In normal subjects a significant inverse relationship was found between erythrocyte (Na+-K+)ATPase activity and cellular Na ÷ content (r = -0.96, p < 0.01), whereas no significant relationship was observed in diabetic patients (r = -0.2). K cellular content did not correlate significantly with (Na+-K+)ATPase activity either in control subjects (r= 0.14) or diabetic patients (r = 0.22). To ascertain whether the reduction in the enzyme activities observed in diabetic patients were influenced by the metabolic control, correlations were studied between the indices of the metabolic control and the enzyme activities. Neither (Na+-K+)ATPase nor (Mg2+)ATPase activity was significantly related to fasting blood glucose (r= -0.1 and r---0.06 respectively), or to insulin )dosage (r = 0.I for both). HbA1 was significantly correlated with (Na+-K+)ATPase activity (Fig.l) , but not with (MgZ+)ATPase activity (r= -0.014). Thus, subjects with an apparently better metabolic control exhibited a lower value of (Na+-K+)ATPase activity. In control subjects no significant correlation was observed between (Na+-K+)ATPase activity and HbAv The reduction in the enzyme activities was also independent of duration of diabetes or age at diagnosis of disease, since these two indices did not significantly correlate with (Na+-K+)ATPase (r= 0.26 and r= -0.24 respectively) or (Mg2+)ATPase activity (r= -0.1 and r= 0.24 respectively). Neither was any significant relationship found between age and erythrocyte (Na+-K+)ATPase activity in both diabetic patients and control subjects (r---3.95 x l0 -3 and r= -5.7 x 10 -2 respectively). No difference was found between diabetic and normal subjects with regard to the plasmatic composition of ions, proteins and lipids.
It has been reported by several investigators that in essential hypertensive subjects, as well as in their normotensive offsprings, a circulating factor is present that affects the activity of the sodium potassium pump [13, 24] . To see whether a similar factor is also present in diabetic plasma, erythrocyte membranes from each diabetic subject were incubated with their own plasma and with plasma from a randomly drawn control subject, and vice versa. Cross-incubation experiments were performed with dialyzed plasma, since at dilutions lower than 1/25 non-dialyzed plasma interfered with the assay method. At concentrations that produced no interference, the effects of non-dialyzed plasma were virtually identical to those of dialyzed plasma. Serum was as effective as dialyzed plasma in stimulating the (Na+-K+)ATPase activity. The dose-effect curves (percentage increase in enzyme activity vs plasma dilution) are shown in Figure 2 . Diabetic plasma stimulated the (Na+-K+)ATPase activity of diabetic erythrocyte membranes in a dose-dependent manner to a maximum of 96% (_+ 21.3) (left panel in Fig. 2) . The curve obtained dearly indicates that the stimulatory activity is a saturable phenomenon consistent with the hypothesis of a The effect of scalar dilutions of dialyzed diabetic and normal plasma on partially purified beef heart (Na+-K+)ATPase activity is shown in Figure 3 . Like the diabetic erythrocyte enzyme, beef heart (Na+-K+)ATPase was stimulated about 100% by diabetic plasma, and the concentration response curve again indicated saturation kinetics. Normal plasma also produced a significant stimulation of beef heart ATPase activity (maximum activation: 62.5% + 15.68, Fig. 3 ), although at each dilution it was lower than that observed with diabetic plasma (Fig. 3 : significant differences starting from 1/100dilution, p < 0.05 Wilcoxon's rank: sum test). The stimulation of beef heart (Na +-K+)ATPase by diabetic plasma was directly related to the plasma protein concentration. Thus, in order to exclude a non-specific stimulatory effect mostly due to plasma albumin, in separate experiments bovine serum albumin was added to the ATPase assay at the final concentration of i mg/ml. The (Na+-K +) ATPase activity was stimulated to a maximum of 13.2% +4.52 by bovine serum albumin, a value lower than that observed with the same protein concentration of plasma (65% _+ 7.1).
Duration of diabetes did not influence the stimulatory property of diabetic plasma (r = -0.06) nor apparently did the metabolic control, since the stimulation of the (Na+-K+)ATPase activity was not related to fasting blood glucose (r = -0.33), HbA1 (r = 0.28) or daily insulin dosage (r= 0.014).
Since diabetic plasma yielded a constantly higher activation of (Na+-K+)ATPase than did normal plasma, attempts were made to characterize the factor responsible for this stimulatory effect.
After ultrafiltration of plasma and serum, no stimulatory activity was detected in the filtrate and the amount of activator in the concentrate roughly accounted for all of that in the initial material. The plasma activating property was lost after treatment with perchloric acid as well as after boiling plasma for 5 min. The exposure of plasma at 60 °C for 20 min, on the contrary, did not reduce its stimulatory property. After treatment with chloroform-methanol, the plasma extract failed to stimulate (Na+-K+)ATPase activity at any dilution employed, thus showing that the lipid phase of plasma did not contain the activator.
Discussion
Impaired (Na+-K+)ATPase activity has been reported to occur in primary essential hypertension even before the clinical onset of the disease either in animals [251 or man [11, 12] . Since it is known that diabetic patients are more susceptible to hypertensive disease than the normal population [1] , it is conceivable that biochemical alterations similar to those observed in primary hypertension may also occur in human diabetes at the level of the cation transport systems of the cellular membrane. The present study has shown that a biochemical lesion is present in erythrocyte membranes of Type 1 diabetic patients, as revealed by a significant reduction in the (Na+-K+)ATPase activity. A decreased (Na+-K ÷) ATPase activity has been recently observed in experimentally-induced diabetes in rabbits [26] and rats [271. The factor(s) responsible for the reduced enzyme activity are not known at present. However, the available evidence suggests that the altered physical state of the lipid moiety of diabetic membrane may constitute a plausible molecular basis for the (Na+-K+)ATPase dysfunction. Indeed, it has been shown that in diabetes the microviscosity of the phospholipid bilayer of erythrocyte membrane is increased [281. An increase in cholesterol content, which is known to increase the membrane stiffness [29] , has been observed in diabetic rat heart sarcolemma [27] . Since the (Na+-K+)ATPase activity is critically dependent on the composition and the fluidity of the surrounding phospholipid bilayer [29] , the alterations observed in diabetic membranes are most likely accompanied by a reduced enzyme activity. The finding that (Na+-K÷)ATPase of diabetic membranes is stimulated by diabetic plasma to a significantly greater extent (96%) than (Na+-K+)ATPase of normal membranes (48%) is consistent with the hypothesis that the two ATPase systems are in different functional states. If the reduced enzyme activity of diabetic erythrocyte membranes would merely reflect a decrease in the number of (Na+-K+)ATPase molecules per unit of membrane weight, the same percent stimulation should be observed. The fact that the activation is observed in the presence of saturating concentrations of Na +, K + and ATP suggests that the stimulatory effect is due to an increase in the turnover number of the enzyme rather than to an increase in the substrate affinity.
This work has also shown that the reduced activity of diabetic (Na+-K+)ATPase is not accompanied by a concomitant increase in cellular Na + content. As a consequence, the significant inverse relation between (Na +-K +)ATPase activity and cellular Na + content observed in normal subjects is lost in the diabetic population. This might be taken as an indication that the sodium potassium pump has no longer a primary role in regulating the cellular electrolyte homeostasis in diabetic patients. However, the finding that diabetic plasma possesses a stimulatory activity on (Na+-K+)ATPase that is significantly higher than that of normal plasma suggests an alternative explanation. According to this explanation, the Na + cellular content is maintained within normal limits since the stimulation by plasma in vivo compensates for the reduced basal activity of (Na+-K+)ATPase. It is suggested that the stimulatory activity of diabetic plasma is due to the presence of a factor that interacts specifically with (Na +-K+)ATPase. This suggestion is supported by the following observations: 1) the plasma stimulatory activity exhibits saturation kinetics, as is to be expected for a specific ligandreceptor interaction; 2) the same saturation kinetics is found with a (Na+-K+)ATPase from a different source (beef heart); 3) Mg2+-ATPase activity is unaffected by diabetic plasma; 4) the stimulatory activity is not lost upon dialysis of plasma, indicating that the observed stimulation is not due to possible differences in ion composition between diabetic and normal plasma. A non-specific stimulatory effect of plasma was also excluded, since diabetic patients and control subjects were similar for plasma proteins and lipids and the stimulation of (Na+-K+)ATPase by bovine serum albumin was always significantly lower than that obtained with a corresponding protein concentration of plasma.
The results of experiments aimed at characterizing the plasma activating factor indicate that the stimulatory property is due to a proteinaceous, relatively thermostable substance with an apparent molecular weight greater than 50,000. Thus, a stimulating activity due to low molecular weight proteins such as insulin, or to a lipid substance can be ruled out. Experiments are in progress to better identify the nature and the properties of this activating substance.
Experiments on beef heart ATPase indicate that also control plasma shows a significant stimulatory property. This result suggests that the significant differences observed between control and diabetic plasma are likely quantitative, although qualitative differences cannot be excluded.
The stimulatory property of diabetic plasma is not influenced by duration of diabetes nor is it related to fasting blood glucose, HbA1 or daily insulin dosage. Likewise, basal erythrocyte (Na+-K+)ATPase activity appears unrelated to the duration of the disease or the degree of the metabolic control, since no significant relationship is found between enzyme activity and fasting blood glucose or insulin dosage. The direct, highly significant, relationship observed between (Na+-K +) ATPase activity and HbA1 is not in contrast with the foregoing conclusions. If the reduced enzyme activity observed in diabetic patients were the consequence of a poor metabolic control, then an inverse relationship should be observed between (Na+-K+)ATPase activity and HbA1 levels. This result can be explained by considering that the activities of both the (Na +-K+)ATPase and the glucose transporter may be similarly reduced in consequence of the altered physical properties of the diabetic membranes. Indeed, both enzyme systems are integral membrane proteins whose activity is critically dependent on the bilayer viscosity [29, 301. According to this explanation, the decreased (Na +-K+)ATPase activity is accompanied by a lower level of HbA1 since the reduced efficiency of the glucose transporter limits the glycosylation of haemoglobin.
These considerations, together with the finding that all diabetic patients examined were free of clinically apparent vascular complications, suggest that both the reduction in (Na+-K+)ATPase activity and the stimulatory activity of diabetic plasma represent early alterations in the course of diabetes mellitus.
